EP3311666
Díketón og hýdroxýketón sem örvar katenín boðferlis
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.8.2011EP published:
5.5.2021EP application number:
17193280.9
EP translation filed:
15.6.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
16.8.2031Expiry date:
16.8.2023
Title:
DIKETONES AND HYDROXYKETONES AS CATENIN SIGNALING PATHWAY ACTIVATORS
Timeline
Today
17.8.2011EP application
5.5.2021EP Publication
15.6.2021Translation submitted
15.7.2021Registration published
16.8.2023Expires
Owner
Name:
BioSplice Therapeutics, Inc.Address:
9360 Towne Centre Drive, San Diego, CA 92121, US
Inventor
Name:
KC, Sunil KumarAddress:
San Diego, CA 92127, US
Name:
WALLACE, David MarkAddress:
San Diego, CA 92121, US
Name:
HOOD, JohnAddress:
San Diego, CA 92130, US
Name:
BARROGA, Charlene F.Address:
San Diego, CA 92122, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
374687 PDate:
18.8.2010Country:
US
Number:
201061427974 PDate:
29.12.2010Country:
US
Classification
Categories:
A01N 35/00, A61K 31/12, C07D 319/18, C07D 405/06, C07D 405/10, C07D 407/10, C07D 409/06, C07D 409/10, C07C 49/784, C07D 213/50, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 30.7.2021
Expires: 16.8.2022
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 2.8.2022
Expires: 16.8.2023
Payer: Patice ehf.